General drug-use survey for Corectim

JRCT ID: jRCT2031210295

Registered date:05/09/2021

Basic Information

• Recruitment status: Not Recruiting
• Health condition(s) or Problem(s) studied: Dermatitis atopic
• Date of first enrollment: 22/10/2021
• Target sample size: 3000
• Study type: Observational

Outcome(s)

Primary Outcome

Incidence of onset of skin infection
Incidence of onset of malignant tumor

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Both

Include criteria

(1) Patients using Corectim for the first time for dermatitis atopic
(2) Patients or their surrogates must provide informed consent before the start

• Exclude criteria: None

Related Information

• Primary Sponsor: Dept. and Pharmacovigilance Patient Safety